CN107723334A - 一种产ESBLs细菌检测试剂和检测产ESBLs细菌的试剂盒 - Google Patents

一种产ESBLs细菌检测试剂和检测产ESBLs细菌的试剂盒 Download PDF

Info

Publication number
CN107723334A
CN107723334A CN201711285970.0A CN201711285970A CN107723334A CN 107723334 A CN107723334 A CN 107723334A CN 201711285970 A CN201711285970 A CN 201711285970A CN 107723334 A CN107723334 A CN 107723334A
Authority
CN
China
Prior art keywords
esbls
production
detection
hole
bacteriums
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711285970.0A
Other languages
English (en)
Inventor
郑业焕
汪礼琴
鲁清月
伊首璞
方娟
吕高原
崔晓莉
丰欣欣
付光宇
吴学炜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Autobio Diagnostics Co Ltd
Original Assignee
Autobio Diagnostics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autobio Diagnostics Co Ltd filed Critical Autobio Diagnostics Co Ltd
Priority to CN201711285970.0A priority Critical patent/CN107723334A/zh
Publication of CN107723334A publication Critical patent/CN107723334A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

本发明公开了一种产ESBLs细菌检测试剂,其中包括胰酪胨、酵母浸粉、牛肉浸粉、NaCl、3‑吗啉丙磺酸、丙酮酸钠、硝酸钾、海藻糖、酚红、亚甲基蓝、制霉菌素、牛胆盐、万古霉素等成分。为方便检测,本发明将该检测试剂应用于检测产ESBLs细菌试剂盒中。本发明通过科学配制的检测试剂,可对样本中的产ESBLs细菌进行直接检测,且试剂成本低;通过在检测板上包被特殊底物、生长因子、抑制剂,使产ESBLs细菌特异性生长,从而对产ESBLs细菌进行及时检测,给临床提供了科学有效的指导,对预防控制院内感染的流行具有重要价值,而检测结果只需要目测,无需借助其他专用设备,满足了不同客户群的需求;同时由于其检测周期短,24小时内即能出结果,有利于患者的早期诊断和治疗。

Description

一种产ESBLs细菌检测试剂和检测产ESBLs细菌的试剂盒
技术领域
本发明涉及体外诊断技术领域,尤其是涉及一种产ESBLs细菌检测试剂,本发明还涉及检测产ESBLs细菌的试剂盒。
背景技术
超广谱β-内酰胺酶(extended-spectrum β-lactamase,ESBLs)是肠杆菌科细菌对β-内酰胺类抗菌药物产生耐药的主要机制之一,自1982年在英格兰首先发现产超广谱β-内酰胺酶(extended-spectrum β-lactamase,ESBLs)克雷伯菌后,产ESBLs细菌的流行在世界各地广泛报道,其预防与治疗已成为临床医生需要面对的重要问题。ESBLs主要存在于临床分离的革兰阴性杆菌,其中又多见于肠杆菌科细菌。在肠杆菌科细菌中以大肠埃希菌和克雷伯菌最为常见,克雷伯菌包括肺炎克雷伯菌和产酸克雷伯菌。其他常见产ESBLs细菌有产气肠杆菌、变形杆菌、沙门属菌、阴沟肠杆菌、粘质沙雷菌、铜绿假单胞菌、不动杆菌属等。
各个国家和地区产ESBLs细菌的发生率明显不同。日本、荷兰等国家产ESBLs细菌的发生率很低,而法国、印度等国家产ESBLs细菌的发生率很高,可有高达50%以上的克雷伯菌属的细菌产生ESBLs,而且具有较严重的耐药性。我国大陆不同研究者报告的产ESBLs细菌发生率各有不同,大肠埃希菌发生率大约在40%,肺炎克雷伯菌发生率更低一些。
产ESBLs细菌主要在医院内引起感染和流行,其中60%发生在大型医院,特别是教学医院。产ESBLs细菌不仅能引起院内暴发流行,还可以向院外传播,使流行范围扩大。研究显示,重症监护病房、住院日延长(≥7d)、机械通气、导尿管和动脉导管的留置、严重疾病状态(如器官移植)、不适当联合使用抗菌药物或三代头孢菌素、年龄≥60岁等都是导致产ESBLs细菌感染的危险因素。
临床产ESBLs细菌的检测方法主要包括有:纸片扩散法(K-B法),肉汤稀释(MIC)法,琼脂稀释(MIC)法,浓度梯度(E试验)法,自动化药敏检测,琼脂显色筛选法及分子生物学技术。其中纸片扩散法(K-B法),肉汤稀释(MIC)法,琼脂稀释(MIC)法,浓度梯度(E试验)法,自动化药敏检测这几种方法是传统的耐药菌检测主要方法和手段,是公认的敏感性检测方法,也是当前临床耐药菌检测的主要方法,但是这些检测方法面对的均是临床分离活化后的菌株,针对临床样本是无法直接使用的,存在操作麻烦、检测周期长的问题。琼脂显色筛选法和分子生物学法是近几年新型的耐药菌检测技术,可以直接进行耐药菌的检测,有效缩短了检测周期,但由于检测成本高,在使用中受到一定的限制。
发明内容
本发明的目的在于提供一种产ESBLs细菌检测试剂,本发明还提供操作方便、检测周期短且成本低的产ESBLs细菌检测试剂盒。
为实现上述目的,本发明可采取下述技术方案:
本发明所述的产ESBLs细菌检测试剂,其检测试剂溶液中包括有以下成分(按质量浓度计):0.1~3%的胰酪胨,0.1~2%的酵母浸粉,0.05~1%的牛肉浸粉,0.1~2%的NaCl,0.05~2%的3-吗啉丙磺酸,0.05~2%的丙酮酸钠,0.05~2%的硝酸钾,0.05~2%的海藻糖,0.006%的酚红,0.0001-0.01%的亚甲基蓝,0.001%的制霉菌素,0.015%的牛胆盐,0.001%的万古霉素。
本发明所述的一种产ESBLs细菌检测试剂盒,包括带有培养液、矿物油和检测板的盒体,所述检测板上间隔设置有阳性孔和产ESBLs细菌检测孔;所述阳性孔和产ESBLs细菌检测孔内分别包被有上述检测试剂,其中每孔的包被量为100ul;所述培养液为含有0.5-1%的氯化钠溶液,所述矿物油为液体石蜡油。
所述产ESBLs细菌检测孔至少包含检测头孢噻肟、头孢他啶和氨曲南三种抗生素中一种以上的产ESBLs细菌的检测孔。
所述头孢噻肟检测孔中包被有1-8ug/mL的头孢噻肟,所述头孢他啶检测孔中包被有1-8ug/mL的头孢他啶;所述氨曲南检测孔中包被有1-8ug/mL的氨曲南,每孔的包被量均为100ul。
本发明试剂盒使用时,首先将待检样本加入培养液中搅拌混匀,然后将其分别接种进阳性孔和产ESBLs细菌检测孔中,每孔100 ul;再分别滴加一滴矿物油,盖上检测板盖后置于36~38℃培养,24h后通过颜色变化直接观察结果。
本发明的优点在于通过科学配制的检测试剂,可对样本中的产ESBLs细菌进行直接检测,且试剂成本低;将其制作成试剂盒后,由于在检测板的检测孔内包被了包含胰酪胨、酵母浸粉、牛肉浸粉等具有丰富营养成分和生长因子的物质,并选择制霉菌素、牛胆盐、万古霉素等作为抑制剂,因此能使产ESBLs细菌特异性生长,从而对产ESBLs细菌进行及时检测,给临床提供了科学有效的指导,对预防控制院内感染的流行具有重要价值,而检测结果只需要目测,无需借助其他专用设备,满足了不同客户群的需求;同时由于其检测周期短,24小时内即能出结果,有利于患者的早期诊断和治疗。
附图说明
图1是本发明试剂盒的结构示意图。
图2是图1中检测板的放大图。
具体实施方式
下面通过具体实施例对本发明做更加详细的说明。
本发明配制的产ESBLs细菌检测试剂溶液中包含有以下成分:0.1~3%的胰酪胨(优选2%),0.1~2%的酵母浸粉(优选1%),0.05~1%的牛肉浸粉(优选0.2%),0.1~2%的NaCl(优选2%),0.05~2%的3-吗啉丙磺酸(优选1%),0.05~2%的丙酮酸钠(优选0.05%),0.05~2%的硝酸钾(优选0.5%),0.05~2%的海藻糖(优选0.5%),0.006%的酚红,0.0001-0.01%的亚甲基蓝(优选0.002%),0.001%的制霉菌素,0.015%的牛胆盐,0.001%的万古霉素。
为方便检测,本发明将上述检测试剂应用于检测产ESBLs细菌的试剂盒中,如图1所示,该试剂盒包括带有培养液1、矿物油2和检测板3的盒体4,在检测板3上间隔设置有阳性孔3.1和产ESBLs细菌检测孔,将上述配制的检测试剂按每孔100 ul的包被量对阳性孔3.1和检测孔进行包被。实际制作时,产ESBLs细菌检测孔可以设计为一个(仅测量一种产ESBLs细菌),也可以同时设计两个或更多。
本发明的产ESBLs细菌检测孔设计有三个,如图2所示,一次性可以同时对三种不同的产ESBLs细菌进行检测:包被有1-8ug/mL(优选5ug/mL)头孢噻肟的检测孔3.2,包被有1-8ug/mL(优选5ug/mL)头孢他啶的检测孔3.3,包被有1-8ug/mL(优选5ug/mL)氨曲南的检测孔3.4;每孔的包被量同样都为100ul。
本发明试剂盒所用的培养液1为含有0.5-1%的氯化钠溶液,所用矿物油2为液体石蜡油。
使用时,将待检样本加入培养液1中搅拌混匀;然后将其接种入检测板3的阳性孔3.1和三个检测孔3.2、3.3、3.4中,每孔100 ul,然后分别滴加矿物油2一滴,盖上检测板盖后置于36~38℃培养,24h观察结果,如果孔内有菌生长,则颜色从蓝紫色变为黄色或其他颜色,具体判断方法如下:
若阳性孔3.1不变色,无论检测孔是否变色,待检样本均判断为阴性;
若阳性孔3.1变色,但头孢噻肟检测孔3.2,头孢他啶检测孔3.3,氨曲南检测孔3.4均不变色,则待检样本为阴性;
若阳性孔3.1变色,且头孢噻肟检测孔3.2,头孢他啶检测孔3.3,氨曲南检测孔3.4三个检测孔中有一个或多个变色,则待检样本为阳性。

Claims (4)

1.一种产ESBLs细菌检测试剂,其特征在于:所述检测试剂溶液中包括有以下成分:0.1~3%的胰酪胨,0.1~2%的酵母浸粉,0.05~1%的牛肉浸粉,0.1~2%的NaCl,0.05~2%的3-吗啉丙磺酸,0.05~2%的丙酮酸钠,0.05~2%的硝酸钾,0.05~2%的海藻糖,0.006%的酚红,0.0001-0.01%的亚甲基蓝,0.001%的制霉菌素,0.015%的牛胆盐,0.001%的万古霉素。
2.一种产ESBLs细菌检测试剂盒,包括带有培养液、矿物油和检测板的盒体,其特征在于:所述检测板上间隔设置有阳性孔和产ESBLs细菌检测孔;所述阳性孔和产ESBLs细菌检测孔内分别包被有权利要求1所述的检测试剂;所述培养液为含有0.5-1%的氯化钠溶液,所述矿物油为液体石蜡油。
3.根据权利要求2所述的产ESBLs细菌检测试剂盒,其特征在于:所述产ESBLs细菌检测孔至少包含检测头孢噻肟、头孢他啶和氨曲南三种抗生素中一种以上的产ESBLs细菌的检测孔。
4.根据权利要求3所述的产ESBLs细菌检测试剂盒,其特征在于:所述头孢噻肟检测孔中包被有1-8ug/mL的头孢噻肟,所述头孢他啶检测孔中包被有1-8ug/mL的头孢他啶;所述氨曲南检测孔中包被有1-8ug/mL的氨曲南,每孔的包被量均为100ul。
CN201711285970.0A 2017-12-07 2017-12-07 一种产ESBLs细菌检测试剂和检测产ESBLs细菌的试剂盒 Pending CN107723334A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711285970.0A CN107723334A (zh) 2017-12-07 2017-12-07 一种产ESBLs细菌检测试剂和检测产ESBLs细菌的试剂盒

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711285970.0A CN107723334A (zh) 2017-12-07 2017-12-07 一种产ESBLs细菌检测试剂和检测产ESBLs细菌的试剂盒

Publications (1)

Publication Number Publication Date
CN107723334A true CN107723334A (zh) 2018-02-23

Family

ID=61220882

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711285970.0A Pending CN107723334A (zh) 2017-12-07 2017-12-07 一种产ESBLs细菌检测试剂和检测产ESBLs细菌的试剂盒

Country Status (1)

Country Link
CN (1) CN107723334A (zh)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003089652A2 (en) * 2002-04-19 2003-10-30 Biolog, Inc. Comparative phenotype analysis of cells, including testing of biologically active compounds
WO2008114001A1 (en) * 2007-03-16 2008-09-25 The Lewisham Hospital Nhs Trust Esbl detection kit and method
WO2017060427A1 (en) * 2015-10-09 2017-04-13 Universite De Fribourg Kit and Methods for the Rapid Detection of the Absence or Presence of a beta-Lactamase in Samples of Body Fluids

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003089652A2 (en) * 2002-04-19 2003-10-30 Biolog, Inc. Comparative phenotype analysis of cells, including testing of biologically active compounds
WO2008114001A1 (en) * 2007-03-16 2008-09-25 The Lewisham Hospital Nhs Trust Esbl detection kit and method
WO2017060427A1 (en) * 2015-10-09 2017-04-13 Universite De Fribourg Kit and Methods for the Rapid Detection of the Absence or Presence of a beta-Lactamase in Samples of Body Fluids

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
吕厚乐: "《医学微生物学实验与学习指导》", 30 June 2014 *
好医生医学教育中心: "《乡镇卫生院卫生技术人员 培训教材 供呼吸内科、检验医师、放射科医师使用》", 30 June 2008 *

Similar Documents

Publication Publication Date Title
Saravanan et al. The prevalence and drug resistance pattern of extended spectrum β–lactamases (ESBLs) producing Enterobacteriaceae in Africa
Stuart et al. Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae
Metwally et al. High prevalence of Klebsiella pneumoniae carbapenemase-mediated resistance in K. pneumoniae isolates from Egypt.
JPH09511917A (ja) サルモネラ菌の同定法および培地
EP1791971A4 (en) DEVICE AND METHOD FOR DETECTING ANTIBIOTICATINATING ENZYMES
JP7376625B2 (ja) 細菌における抗微生物剤耐性を検出するための組成物、方法、システムおよび/またはキット
Oteo et al. Microbiological methods for surveillance of carrier status of multiresistant bacteria
Mamza et al. Beta-lactamase Escherichia coli and Staphylococcus aureus isolated from chickens in Nigeria
JP2012504951A (ja) 黄色ブドウ球菌バクテリア用の反応培地
Bou et al. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings
Villa et al. Reliability of a multiplex PCR system for diagnosis of early and late prosthetic joint infections before and after broth enrichment
Acharya et al. Sabouraud agar and other fungal growth media
CN1699592A (zh) 双相罗氏培养基及其制备方法
Li et al. Detection of AmpC β-lactamase-producing Gram-negative bacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
JP7479433B2 (ja) クラスa型カルバペネマーゼ産生菌の検出方法および検出用多ウェルプレート
CN101874118A (zh) 检测和/或鉴定金黄色葡萄球菌的反应培养基
CN107723334A (zh) 一种产ESBLs细菌检测试剂和检测产ESBLs细菌的试剂盒
JP3298932B2 (ja) 多剤耐性ブドウ球菌を選択的に培養するための培地
Tamtami et al. Imported case of melioidosis in Oman: Case report
JP7314230B2 (ja) インフルエンザ菌のスクリーニング方法およびスクリーニング用培地
Alshaikh et al. Correlation between antimicrobial resistance, biofilm formation, and virulence determinants in uropathogenic Escherichia coli from Egyptian hospital
Kiratisin et al. Genotypic analysis of plasmid-mediated β-lactamases amongst Enterobacteriaceae other than Escherichia spp. and Klebsiella spp. that are non-susceptible to a broad-spectrum cephalosporin
US8846336B2 (en) Test mixtures for detecting the presence or absence of target microbes
Tetz et al. Evaluation of a new culture-based AtbFinder test-system employing a novel nutrient medium for the selection of optimal antibiotics for critically ill patients with polymicrobial infections within 4 h
Chauhan et al. Microbiological culture media: types, role and composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180223